名贵中成药质量研究现状

Current quality research situation of precious Chinese patent medicine

通过对名贵中成药相关文献及国家标准的统计分析,发现名贵中成药剂型以故老剂型为主,单一落后;质量研究以化学物质为基础,标准不完善、缺乏整体性,不能完全反映名贵中成药的质量,这些可能是因为中医理论的"宏观思维"逻辑与现代分析技术"微观研究"的矛盾所导致的。新兴的"代谢组学"和"中药配位化学学说"2种理论具有"整体性"的特点,既能满足中药化学成分分析需要"微观研究"的要求,又符合中医理论的"宏观思维",将是名贵中成药的发展方向。

Along with the development of modern medicinal manufacture and pharmaceutical analysis technology, the precious Chinese patent medicine is also growing quickly. However, after the investigation of the dosage-forms and relative government standards, we find that the precious Chinese patent medicine needs more variety in administration and more precise and full-scale analysis standards based on the chemical materials because of the contradiction between the ＂global thoughts＂ logic in traditional Chinese medicine（TCM） theory and the ＂local study＂ of modern pharmaceutical analysis technology. Currently rising theories, metabonomics and coordination chemistry of TCM, with the superiority of entirety, can not only fulfill the requirement for ＂ local study＂ but also accord with the ＂global thoughts＂ logic in TCM theory. They will be the reasonable guide for the development of the precious Chinese patent medicine.